Search results for "Trocar"

showing 10 items of 451 documents

The Role of Cardiac Pacing in Heart Block Complicating Acute Myocardial Infarction

1983

The organization of the Coronary Care Unit and the use of electrocardiographic monitoring have allowed a re-evaluation of the incidence of the atrioventricular conduction disturbances in acute myocardial infarction.

medicine.medical_specialtyCardiac pacingHeart blockbusiness.industryIncidence (epidemiology)Electrocardiography in myocardial infarctionmedicine.diseaseInternal medicinecardiovascular systemmedicineCardiologyCoronary care unitcardiovascular diseasesMyocardial infarctionbusinessAtrioventricular conduction disturbancesAtrioventricular block
researchProduct

Are double potentials markers of a specific zone of the atrioventricular junction in the isolated rabbit heart?

1997

A study is made of the characteristics of the atrial potentials recorded in the Koch triangle and its proximity, their variations on modifying the site of cardiac pacing, and their usefulness as markers of a distinct zone of the AV junction. In 12 isolated and perfused rabbit heart preparations an analysis was made of the endocardial atrial electrograms recorded with a multiple electrode positioned in the AV junction. The electrograms were obtained during spontaneous rhythm and on pacing at the crista terminalis (CT), interatrial septum (IAS), left atrium, and right ventricle. Double potentials were frequently obtained. On pacing at the CT, high-low double potentials (DP [H-L]) were more fr…

medicine.medical_specialtyCardiac pacingLeft atriumAction PotentialsIn Vitro TechniquesSensitivity and SpecificityElectrocardiographyHeart RateInternal medicinemedicineAnimalsVentricular FunctionAtrioventricular junctionbusiness.industryRabbit heartCardiac Pacing ArtificialGeneral MedicineAnatomyAtrial Functionmedicine.anatomical_structureVentricleCardiologyAtrioventricular NodeRabbitsCardiology and Cardiovascular MedicinebusinessCrista terminalisInteratrial septumPacing and clinical electrophysiology : PACE
researchProduct

A rare case of a coronary artery anomaly detected on multidetector computed tomography

2013

An anomalous aortic origin of the coronary artery arising from the opposite sinus with an interarterial course is a rare condition that is associated with a high risk of sudden cardiac death during or after strenuous exertion. We herein report the case of a 47-year-old woman presenting with chest pain, syncope and palpitations who presented with a rare coronary artery anomaly on multidetector computed tomography coronary artery (MDCT-CA) with prospective electrocardiogram (ECG) gating.

medicine.medical_specialtyCoronary Vessel AnomaliesChest painSudden deathSudden cardiac deathElectrocardiographyInternal medicineMultidetector computed tomographyCoronary artery anomalyMultidetector Computed TomographyInternal MedicinePalpitationsMedicineHumanscardiovascular diseasesSinus (anatomy)business.industryGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structurecardiovascular systemCardiologyExercise TestFemalemedicine.symptombusinesscoronary anomalies coronary computed tomography sudden deathArtery
researchProduct

Cocaine-induced coronary thrombosis and acute myocardial infarction

2004

A 26-year-old man was admitted to our hemodynamic laboratory because of an anterior AMI and post myocardial infarction angina. He is an active smoker (10 cigarettes/day) and consumes inhaled cocaine during weekends (the last consumption of cocaine was 1 week ago). No others risk factors were recorded. Initial electrocardiogram shows sinus rhythm and anterior QS complex (V1–V3) with anterolateral ST segment elevation (V1–V5, D1 and aVL). Creatine-kinase isoenzyme MB and Troponin I were elevated at arrival. Upon admission, the patient was normotensive but with signs of pulmonary congestion. Ventriculography showed anterolateral and apical hypokinesia with an ejection fraction of 21%. Coronari…

medicine.medical_specialtyEjection fractionbusiness.industryElectrocardiography in myocardial infarctionAnterior Descending Coronary Arterymedicine.diseaseThrombosisAnginaCoronary thrombosisRight coronary arterymedicine.arteryInternal medicinemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Silent atrial fibrillation during the acute phase of myocardial infarction

2013

medicine.medical_specialtyEjection fractionbusiness.industryP waveLeft atrium12 lead ecgElectrocardiography in myocardial infarctionElectrographic monitoringAtrial fibrillationmedicine.diseasemedicine.anatomical_structureInternal medicinemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Use of quantitative ECG analysis for early detection and prediction of coronary heart disease

1985

(1985). Use of quantitative ECG analysis for early detection and prediction of coronary heart disease. Medical Informatics: Vol. 10, No. 3, pp. 207-214.

medicine.medical_specialtyElectrodiagnosismedicine.diagnostic_testComputersbusiness.industryEarly detectionCoronary DiseaseHealth informaticsCoronary heart diseaseElectrocardiographyReference ValuesInternal medicinemedicineCardiologyHumansMass ScreeningECG analysisProspective StudiesRisk factorbusinessElectrocardiographyMedical Informatics
researchProduct

Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity.

2014

AbstractBackground: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation.Aim: To quantify serum levels of fibrosis regulators in CHF.Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n = 9; II, n = 34; III n = 23), and in 14 controls.Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1.Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF.

medicine.medical_specialtyHealth Toxicology and MutagenesisClinical BiochemistryInflammationBiochemistryGastroenterologySeverity of Illness IndexBone morphogenetic protein 1ElectrocardiographyFibrosisInternal medicinemedicineEndothelial dysfunction heart fibrosis inflammationHumanscardiovascular diseasesEndothelial dysfunctionHeart Failurebusiness.industryMembrane ProteinsBone Morphogenetic Protein Receptorsmedicine.diseaseFibulinProcollagen peptidaseHeart failureImmunologyChronic Diseasecardiovascular systemBAMBImedicine.symptombusinesscirculatory and respiratory physiology
researchProduct

Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance

2012

Myocardial infarction is a major cause of death and disability worldwide. Myocardial infarction may represent a major catastrophic event leading to severe hemodynamic failure or sudden death or it may occur repeatedly in patients with established heart disease. In this context, the role of imaging techniques may become useful for the understanding of the determinants in a preclinical setting before acute coronary events, and for an accurate and correct diagnosis of myocardial infarction. Three-dimensional noninvasive imaging techniques, such as Cardiac CT (CCT) and Cardiac MR imaging (CMR) were widely developed in the last two decades. These imaging techniques may provide new insights into …

medicine.medical_specialtyHeart diseaseContext (language use)Coronary Artery DiseaseSudden deathInternal medicineMedicineHumanscardiovascular diseasesMyocardial infarctionPharmacologymedicine.diagnostic_testbusiness.industryCoronary StenosisElectrocardiography in myocardial infarctionMagnetic resonance imagingmedicine.diseaseCoronary arteriesMyocardial infarctionmedicine.anatomical_structurecardiovascular systemCardiologyRadiologyMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessMagnetic Resonance AngiographyTomography Emission-Computed
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct